Posts filtered by tags: Vaccines and immunisation[x]


 

Protecting others and record of vaccines main reasons to get Covid jab, poll shows

Survey suggests almost one in two British people expect life to return to normal in a year Coronavirus – latest updatesSee all our coronavirus coveragePreventing others from catching coronavirus and immunisation’s proven success against disease are the main reasons people see for taking the new vaccine, research has shown.In a survey of 1,049 Britons, the top two reasons for having it – each cited by 77% – were to protect others from the virus and because vaccines have a long track record of wor...
Tags: Health, Society, UK News, Medical Research, Infectious Diseases, Vaccines and immunisation, Coronavirus


NHS to enlist 'sensible' celebrities to persuade people to take coronavirus vaccine

Exclusive: People who are ‘known and loved’ will front campaign amid fears of low take-upCoronavirus – latest updatesSee all our coronavirus coverageNHS bosses plan to enlist celebrities and “influencers” with big social media followings in a major campaign to persuade people to have a Covid vaccine amid fears of low take-up.Ministers and NHS England are drawing up a list of “very sensible” famous faces in the hope that their advice to get immunised would be widely trusted, the Guardian has lear...
Tags: Health, England, UK News, NHS, Health policy, Vaccines and immunisation, NHS england, Coronavirus


China hopes ‘vaccine diplomacy’ will restore its image and boost its influence

Trading allies such as Brazil are at the head of the queue for Beijing’s huge drug distribution programme Coronavirus – latest updatesSee all our coronavirus coverageThere was no VIP on board the plane from China that arrived in São Paulo airport earlier this month, but the state governor, João Doria, nonetheless led a high-level welcome delegation gathered on the tarmac.The masked dignitaries were there to mark the arrival of seven refrigerated containers of vaccines, posing for official photos...
Tags: Health, China, Americas, Society, World news, Beijing, Asia Pacific, Infectious Diseases, Brazil, Vaccines and immunisation, Sao Paulo, Doria, João Doria, Coronavirus


It's only fake-believe: how to deal with a conspiracy theorist

As the pandemic has taken a grip, so have the misinformation spreaders. Here are five ways to spot the holes in their logicUnless you’ve been on a silent retreat for the past year, you will have almost certainly heard the rumours – that the pandemic is an elaborate hoax, or that the virus was created as a Chinese weapon, or that dangerous elites are trying to kill off the elderly and to establish a new world order, or that the symptoms are caused by 5G.It is troubling enough to see these ideas o...
Tags: Science, Social Media, Society, World news, Infectious Diseases, Bill Gates, Vaccines and immunisation, 5g, Coronavirus


Life after Covid: will our world ever be the same?

From cities, to science, to politics, six Observer writers assess how a post-pandemic world will emerge into a new normalCoronavirus – latest updatesSee all our coronavirus coverageHere are some things that the pandemic changed. It accustomed some people – those whose jobs allowed it – to remote working. It highlighted the importance of adequate living space and access to the outdoors. It renewed, through their absence, an appreciation of social contact and large gatherings. It showed up mass da...
Tags: Health, Politics, Science, Society, UK News, Work & careers, Cities, Culture, Vaccines and immunisation, Ts Eliot, Coronavirus


There’s a social pathogen stalking the world that’s as deadly as Covid-19 | Kenan Malik

The endurance of TB and malaria shows how health resources are hoarded by the wealthy“What if tropical diseases had as much attention as Covid?” asked Francine Ntoumi, director of the Congolese Foundation for Medical Research, recently. Ntoumi was really asking two questions. What is happening to all the other diseases that ravage the global south as the world’s attention has focused on Covid-19? And why can’t we put as much energy and resources into tackling diseases such as malaria and TB as w...
Tags: India, Africa, World news, South Africa, Brazil, Health policy, Vaccines and immunisation, Aids and HIV, Malaria, Tuberculosis, Kenan Malik, COVID, Francine Ntoumi, Congolese Foundation for Medical Research, Ntoumi


Australia's Covid vaccines: everything you need to know

Analysis: As pharmaceutical companies release trial results, many questions remain about controlling coronavirus. Here is what we knowAround the world about 200 Covid-19 candidate vaccines are being developed, with more than 40 in human clinical trial stage. The Australian government has agreements to secure four of the most promising vaccines, and will roll them out if they prove to be safe and effective.All four vaccines require two doses, spaced a few weeks apart. As the pharmaceutical compan...
Tags: Health, Australia, Australia news, Vaccines and immunisation, Coronavirus


Nadhim Zahawi appointed minister in charge of Covid-19 vaccine rollout

UK business minister to take on additional role as NHS prepares for mass deploymentCoronavirus – latest updatesSee all our coronavirus coverageNadhim Zahawi, the minister for business and industry, has been placed in charge of overseeing the deployment of the Covid-19 vaccine, Downing Street has announced.No 10 said the Stratford-on-Avon MPwould take on the role until at least next summer. Continue reading...
Tags: Health, Politics, UK, Science, Society, UK News, Public services policy, Medical Research, Infectious Diseases, NHS, Microbiology, Health policy, Vaccines and immunisation, Avon, Stratford, Nadhim Zahawi


Is it worth carrying on as a guinea pig, if a vaccine has already been found? Francis Beckett

I am 75 and taking part in the Novavax trial but the success of the Oxford jab has given me a dilemmaMy third appointment with researchers this week, as a participant in Covid-19 vaccine trials, was overshadowed by the news that the Oxford vaccine will probably be available to older folk like me in the early part of next year – maybe as early as January or February.The vaccine I am trialling – the Novavax one – will have test results in January, and probably be available in the summer. So what h...
Tags: Health, Oxford, Older people, Vaccines and immunisation, Novavax, Coronavirus, Francis Beckett


Extremely vulnerable in UK given high priority for coronavirus vaccine

Those with conditions such as blood, bone or lung cancer put in same category on interim guidance list as over-70sCoronavirus – latest updatesSee all our coronavirus coveragePeople at very high risk of contracting coronavirus due to health problems, who were made to shield during the pandemic, have been given the same priority as the over-70s to receive a Covid-19 vaccine.People aged 18 or older deemed “clinically extremely vulnerable” are in the same priority group as those aged 70 and over, ac...
Tags: Health, UK, Science, UK News, Infectious Diseases, Vaccines and immunisation, Coronavirus, Public Health England Continue


No 10 wanted union flag on Oxford coronavirus vaccine kits

Plan hatched by new ‘Union unit’ to counter rise in Scottish nationalismCoronavirus – latest updatesSee all our coronavirus coverageDowning Street tried to get doses of the Oxford University/AstraZeneca coronavirus vaccine labelled with an image of the union jack, it has emerged, as scientists and statisticians raised more questions over the press release that proclaimed the trial’s success.The request for injection kits to bear the flag was driven by No 10’s newly formed “Union unit”, which is ...
Tags: Health, Politics, UK, Science, Scotland, Conservatives, UK News, Oxford, Health policy, Scottish Independence, ` Union, Scottish politics, Boris Johnson, Vaccines and immunisation, Coronavirus, Oxford University AstraZeneca


Escaped infected Danish mink could spread Covid in wild

Scientists fear fur farm animals in wild could create ‘lasting’ Covid reservoir that could then spread back to humansEscaped mink carrying the virus that causes Covid-19 could potentially infect Denmark’s wild animals, raising fears of a permanent Sars-CoV-2 reservoir from which new virus variants could be reintroduced to humans.Denmark, the world’s largest exporter of mink fur, announced in early November that it would cull the country’s farmed mink after discovering a mutated version of the vi...
Tags: Health, Europe, Animals, Environment, World news, Infectious Diseases, Wildlife, Animal Welfare, Microbiology, Denmark, Vaccines and immunisation, Coronavirus


BioNTech's Covid vaccine is a triumph of innovation and immigration | Hans-Werner Sinn

Pioneered by a Turkish-German couple, its significance exceeds its practical valueThe world took note when the German startup BioNTech announced its breakthrough in the development of a new type of vaccine to combat Covid-19. After testing tens of thousands of people, BioNTech’s vaccine has been shown to be 95% effective in providing protection for those who would otherwise have been infected. The company was the first to apply for emergency use authorisation for a coronavirus vaccine in the US ...
Tags: Health, Europe, Business, Science, Biology, Germany, US, Society, US news, Genetics, Medical Research, Infectious Diseases, Microbiology, Pharmaceuticals industry, Vaccines and immunisation, Pfizer


Will everyone in the world have access to a Covid vaccine? – video explainer

The hunt for a coronavirus vaccine is showing promise but it is premature to say the end of the pandemic is nigh. Several rich countries have signed a 'frenzy of deals' that could prevent many poor nations from getting access to immunisation until at least 2024. Also, many drug firms are potentially refusing to waive patents and other intellectual property rights in order to secure exclusive rights to any cure.Michael Safi, the Guardian's international correspondent, explains why 'vaccine nation...
Tags: Health, China, India, Africa, UK News, World news, US news, Poverty, Medical Research, Canada, Asia Pacific, Infectious Diseases, Global development, World Health Organization, Pharmaceuticals industry, Vaccines and immunisation


Different age groups may get different Covid vaccines, experts say

Oxford/AstraZeneca planning new trial of lower-dose jab to see how well it works in older peopleCoronavirus – latest updatesSee all our coronavirus coverageConcerns around the efficacy of the Oxford University/AstraZeneca coronavirus jab in older people could lead to different age groups being given different vaccines, experts have said.The partners announced last week that the vaccine had a 70% efficacy overall. For most trial participants – given two full doses, spaced a month apart – the effi...
Tags: Health, Business, Science, Education, Society, World news, Medical Research, Infectious Diseases, Higher Education, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, University of Oxford, Coronavirus, Oxford University AstraZeneca, Oxford AstraZeneca


North Korean hackers tried to disrupt vaccine in South, says spy agency

South Korean intelligence foiled the attempt by secretive regime to infiltrate pharmaceutical companies working on treatmentsSouth Korea’s intelligence agency has foiled attempts by North Korean hackers to disrupt attempts to develop a Covid-19 vaccine, according to officials.Ha Tae-keung, a conservative member of the national assembly who was briefed by intelligence officials, said attempts by the North to target South Korean drugmakers had failed, but did not identify the companies involved. C...
Tags: South Korea, North Korea, Vaccines and immunisation, South, treatmentsSouth Korea


Oxford/AstraZeneca vaccine to undergo new global trial

Share price drops as critics question claim vaccine could protect up to 90% of peopleWhat tier am I in? Latest Covid rules in England post-lockdownCoronavirus – latest updatesSee all our coronavirus coverageThe Oxford University/AstraZeneca vaccine will undergo a new global trial as critics questioned the claim that it could protect up to 90% of people against coronavirus.On Thursday Sir John Bell, Oxford’s regius professor of medicine and the UK government’s life sciences adviser, dismissed sug...
Tags: Health, UK, England, Science, UK News, World news, Medical Research, Vaccines and immunisation, University of Oxford, Lancet, Coronavirus, Oxford University AstraZeneca, Oxford AstraZeneca, John Bell Oxford


A vaccine revolution | podcast

Results from clinical trials have shown that the world has three apparently highly effective vaccines for Covid-19. With the race now on for regulatory approval, production and distribution, is the end of the pandemic within reach?After a gruelling year of successive waves of Covid-19 infections and national lockdowns there has been a burst of good news this month, with three separate vaccine candidates performing extremely well in clinical trials.First, Pfizer and Moderna announced that their v...
Tags: Health, Business, UK, Science, Medical Research, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, Pfizer, Moderna, Coronavirus, First Pfizer


Oxford Covid vaccine hit 90% success rate thanks to dosing error

Participants given first shot at half strength by mistake were found to be better protectedCoronavirus – latest updatesSee all our coronavirus coverageThe Oxford University and AstraZeneca vaccine trials reached 90% efficacy by accident thanks to the “serendipity” of an error that led to some participants receiving half-doses, it has emerged.On Monday scientists revealed that the Oxford vaccine had an overall efficacy of 70%, but could be around 90% effective when administered as a half dose fol...
Tags: UK News, Oxford, Astrazeneca, Vaccines and immunisation, University of Oxford, Oxford University, Coronavirus


Vaccine results bring us a step closer to ending Covid, says Oxford scientist

Latest breakthrough comes as PM says he hopes most at-risk could be immunised by EasterCoronavirus – latest updatesSee all our coronavirus coverageThe world is moving a step closer to ending the coronavirus pandemic, the scientist behind Britain’s first vaccine has declared, as Boris Johnson said he hoped the majority of those most at-risk could be immunised by Easter.Successful trial results for the Oxford University/AstraZeneca vaccine, suggesting it could protect up to 90% of people, are the ...
Tags: Health, Politics, Science, Society, UK News, Medical Research, Britain, Oxford, Health policy, Astrazeneca, Pharmaceuticals industry, Boris Johnson, Vaccines and immunisation, University of Oxford, Coronavirus, COVID


UK coronavirus live: Boris Johnson says new tiers will be tougher than before as he unveils winter Covid plan

Latest updates: PM unveils post-lockdown plan; Starmer says three-tier system is risky; London and South East England still seeing rising casesOxford/ AstraZeneca vaccine has up to 90% efficacyHow a handful of scientists developed Oxford vaccine at speedEverything we know so far about Oxford vaccineUS, Germany and UK could start jabs as early as DecemberCoronavirus – latest global updates 4.20pm GMT The Commons is back, but not the PM.Matt Hancock, the health secretary, is responding to Mark...
Tags: Health, Politics, UK, Science, London, Scotland, Christmas, UK News, Medical Research, Infectious Diseases, Oxford, Nicola Sturgeon, Astrazeneca, Boris Johnson, Vaccines and immunisation, Tory


Oxford AstraZeneca vaccine to be sold to developing countries at cost price

Jab that is part of global initiative to distribute doses will remain at low price ‘in perpetuity’Coronavirus – latest updatesSee all our coronavirus coverageThe coronavirus vaccine produced by Oxford University and AstraZeneca will be available on a non-profit basis “in perpetuity” to low- and middle-income countries in the developing world.The details of arrangements to supply poorer countries came as AstraZeneca revealed the interim results of a phase 3 trial of the vaccine, which is being he...
Tags: Health, Science, Society, World news, Medical Research, Infectious Diseases, Global development, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, University of Oxford, Oxford University, Coronavirus, Oxford AstraZeneca


Oxford AstraZeneca vaccine will be sold to developing countries at cost price

Jab that is part of global initiative to distribute doses will remain at low price ‘in perpetuity’Coronavirus – latest updatesSee all our coronavirus coverageThe coronavirus vaccine produced by Oxford University and AstraZeneca will be available at cost – not for profit – “in perpetuity” to low and middle income countries in the developing world.The details of arrangements to supply poorer countries came as AstraZeneca revealed the interim results of phase 3 trial of a vaccine that is being hera...
Tags: Health, Science, Society, World news, Medical Research, Infectious Diseases, Global development, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, University of Oxford, Oxford University, Coronavirus, Oxford AstraZeneca


UK coronavirus live: Boris Johnson to address MPs about post-lockdown rules for England

Latest updates: PM to unveil post-lockdown plan; London and South East England still seeing rising casesOxford/ AstraZeneca vaccine has up to 90% efficacyHow a handful of scientists developed Oxford vaccine at speedEverything we know so far about Oxford vaccineUS, Germany and UK could start jabs as early as DecemberCoronavirus – latest global updates 3.27pm GMT Boris Johnson will make his statement to MPs on coronavirus at 3.30pm.Mostly he will be explaining the new rules that will apply for...
Tags: Health, Politics, UK, England, Science, London, Scotland, Christmas, UK News, Medical Research, Infectious Diseases, Oxford, Nicola Sturgeon, Astrazeneca, Boris Johnson, Vaccines and immunisation


Covid: Oxford AstraZeneca vaccine has up to 90% efficacy, data reveals

Vaccine developed in UK by AstraZeneca and Oxford University ‘will save many lives’, says scientistCoronavirus – latest updatesSee all our coronavirus coverageThe Covid vaccine developed in the UK by Oxford University and AstraZeneca can protect 70.4% of people from becoming ill and – in a surprise result – up to 90% if a lower first dose is used, results from the final trial show.The Oxford vaccine is the third to produce efficacy results, following Pfizer/BioNTech and Moderna whose vaccines we...
Tags: Health, UK, Science, US, Society, World news, Medical Research, Infectious Diseases, Oxford, Astrazeneca, Vaccines and immunisation, Pfizer, Oxford University, Moderna, Coronavirus, Oxford AstraZeneca


The Covid vaccine results are great news, but it's not all over yet

Oxford/AstraZeneca findings have certain advantages over those from other versionsCoronavirus – latest updatesSee all our coronavirus coverageWithin weeks, the prospects of an end to the pandemic have changed utterly, with three vaccines against Covid-19 reporting good results in final clinical trials and at least one likely to be used before Christmas. But there are still huge challenges ahead.The results from the Oxford University/AstraZeneca vaccine, which is absolutely central to the UK’s va...
Tags: Health, UK, UK News, Medical Research, Infectious Diseases, Health policy, Astrazeneca, Vaccines and immunisation, University of Oxford, Moderna, Coronavirus, COVID, Pfizer BioNTech, Oxford University AstraZeneca, Oxford AstraZeneca


Oxford AstraZeneca results open up Covid vaccine to developing countries

Jab can be kept in fridge and is part of global initiative to distribute doses at limited costCoronavirus – latest updatesSee all our coronavirus coverageThe efficacy of the Oxford University/AstraZeneca vaccine opens the way for a cheap and more easily transportable vaccine to be made available to some of the world’s poorest countries.Unlike the Pfizer-BioNTech vaccine, AstraZeneca’s experimental vaccine is already a part of Covax, the global initiative which hopes to distribute some 2bn doses ...
Tags: Health, Science, Society, World news, Medical Research, Infectious Diseases, Global development, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, University of Oxford, Coronavirus, Oxford University AstraZeneca, Oxford AstraZeneca


How a handful of scientists developed Oxford vaccine at breakneck speed

Team’s coronavirus work built on decades of research pioneered by Sarah Gilbert and Adrian HillOxford AstraZeneca Covid vaccine ‘has up to 90% efficacy’Coronavirus – latest updatesSee all our coronavirus coverageAt the heart of Oxford’s effort to produce a Covid vaccine are half a dozen scientists who between them brought decades of experience to the challenge of designing, developing, manufacturing and trialling a safe vaccine at breakneck speed.Prof Sarah Gilbert, the Kettering-born project le...
Tags: Health, Science, Biology, Society, UK News, Medical Research, Infectious Diseases, Microbiology, Oxford, Vaccines and immunisation, Sarah Gilbert, Kettering, Adrian Hill, Coronavirus, Adrian HillOxford AstraZeneca Covid


Oxford AstraZeneca Covid vaccine has up to 90% efficacy, data reveals

Vaccine developed in UK by AstraZeneca and Oxford University ‘will save many lives’, says scientistCoronavirus – latest updatesSee all our coronavirus coverageA coronavirus vaccine developed in the UK can prevent 70.4% of people from getting Covid-19 and up to 90% if a lower dose is used, according to data.Oxford University and AstraZeneca have announced their jab is effective in preventing many people getting ill and it has been shown to work in different age groups, including the elderly. Ther...
Tags: Health, UK, Science, Society, World news, Infectious Diseases, Oxford, Astrazeneca, Vaccines and immunisation, Oxford University, Coronavirus


Oxford AstraZeneca Covid vaccine has 70% efficacy, data reveals

Vaccine developed by AstraZeneca and Oxford University shows average efficacy of 70% in protecting against virusCoronavirus – latest updatesSee all our coronavirus coverageA coronavirus vaccine developed in the UK can prevent 70.4% of people from getting Covid-19, according to data.Oxford University and AstraZeneca have announced their jab is effective in preventing many people getting ill and it has been shown to work in different age groups, including the elderly. Continue reading...
Tags: Health, UK, Science, Society, World news, Infectious Diseases, Oxford, Astrazeneca, Vaccines and immunisation, Oxford University, Coronavirus